July 7, 2025

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Gem with 91% Potential Upside

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology industry, has been capturing investor attention with its robust pipeline and significant growth potential. Headquartered in..

Prestige Consumer Healthcare (PBH) Stock Analysis: Potential 10% Upside and Steady Revenue Growth for Savvy Investors

Prestige Consumer Healthcare Inc. (PBH), a notable player in the healthcare sector, specializes in the development, manufacturing, and marketing of over-the-counter (OTC) health and personal care..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking a 278% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (PCVX), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to innovative healthcare solutions. Specializing in the development..

Alkermes plc (ALKS) Stock Analysis: Analyst Consensus Points to 42% Upside Potential

Alkermes plc (NASDAQ: ALKS), an Irish biopharmaceutical giant, is capturing the attention of investors with a compelling narrative. Operating within the Healthcare sector, specifically among Drug..

Biogen Inc. (BIIB) Investor Outlook: Analyzing a 29.60% Potential Upside Amidst Strong Analyst Support

Biogen Inc. (NASDAQ: BIIB), a towering figure in the healthcare sector with a market cap of $19.47 billion, offers investors a compelling opportunity with a potential..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 27.08% Potential Upside in the Healthcare Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, is gaining attention from investors due to its promising growth prospects and robust position within..

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking a 114% Potential Upside in the CAR-T Space

Legend Biotech Corporation (NASDAQ: LEGN) is positioned at the forefront of the biotechnology sector with its innovative focus on cell therapies for oncology. With a market..

Gilead Sciences, Inc. (GILD)

⚠️ No article content returned.

..

Avantor, Inc. (AVTR) Stock Analysis: Unpacking the 21.93% Potential Upside

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $9.46 billion,..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 8.15% Upside in the Genomics Powerhouse

Illumina, Inc. (ILMN) stands as a pivotal entity in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $15.96 billion,..

Bio-Techne Corp (TECH) Stock Analysis: Analyst Ratings Highlight 26.61% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a leading player in the biotechnology sector, has captured investor attention with its robust market presence and promising growth potential. With a..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a 92.52% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector should take a closer look at Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage precision oncology company that is..

ResMed Inc. (RMD) Stock Analysis: Navigating a 2.93% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a leading player in the healthcare sector, is capturing the attention of investors with a market cap of $37.68 billion and a..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a Promising 41% Potential Upside

Telix Pharmaceuticals Limited (TLX) is emerging as a compelling player in the biotechnology sector, with its promising portfolio of radiopharmaceutical products and impressive market performance. Based..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A 25% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector specializing in medical devices, offers an intriguing opportunity for investors with a potential upside of..

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the 3.85% Potential Upside in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, is making waves with its strategic focus on women’s health and its diversified portfolio of..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 66% Upside Potential Amid Strong Analyst Ratings

For investors with an eye on the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) offers a compelling opportunity. With a market capitalization of $11.03 billion, BioMarin..

Qiagen N.V. (QGEN) Stock Analysis: A Promising 3.71% Upside Potential for Investors

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers an intriguing proposition for investors eyeing steady growth..

Haleon plc (HLN) Stock Analysis: Exploring a 12.76% Potential Upside and Robust Market Cap

Haleon plc (HLN), a stalwart in the healthcare sector, commands significant attention from investors with its market cap standing robustly at $46.04 billion. As a prominent..

Encompass Health Corporation (EHC) Stock Analysis: A 10.54% Upside Awaits Investors in the Healthcare Sector

Encompass Health Corporation (NYSE: EHC), a leading provider of post-acute healthcare services, has captured investor attention with an enticing potential upside of 10.54%. With its market..

Search

Funds

July 7, 2025

Search

Funds

July 7, 2025

FTSE 100

Funds